ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,094 | 15,494 | -1,076 | 3,934 | 15,375 |
| Depreciation Amortization | 44,612 | 33,742 | 27,928 | 22,343 | 6,900 |
| Income taxes - deferred | -9,134 | -5,180 | 3,560 | -8,911 | -1,877 |
| Accounts receivable | -7,287 | -4,743 | -12,893 | -23,963 | -4,635 |
| Other Working Capital | -14,581 | 5,968 | -5,652 | -9,927 | -13,821 |
| Other Operating Activity | 25,927 | 21,793 | 27,552 | 43,996 | 15,322 |
| Operating Cash Flow | $45,631 | $67,074 | $39,419 | $27,472 | $17,264 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,635 | -5,743 | -10,369 | -4,566 | -2,183 |
| Net Acquisitions | N/A | -16,467 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -20,914 | -5,169 | -97,624 | -144,494 | -30,500 |
| Other Investing Activity | -20,914 | -5,169 | -97,624 | -144,494 | -30,500 |
| Investing Cash Flow | $-27,549 | $-27,379 | $-107,993 | $-149,060 | $-32,683 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 75,000 | 0 | N/A |
| Debt Repayment | -2,707 | -2,813 | 0 | 0 | N/A |
| Common Stock Issued | 5,738 | 2,978 | 353 | 1,570 | 819 |
| Common Stock Repurchased | -1,031 | -659 | -259 | -2,622 | -113 |
| Other Financing Activity | -750 | -27,322 | -2,737 | 323 | 360 |
| Financing Cash Flow | $1,250 | $-27,816 | $72,357 | $-729 | $1,066 |
| Beginning Cash Position | 48,029 | 36,150 | 32,367 | 154,684 | 169,037 |
| End Cash Position | 67,361 | 48,029 | 36,150 | 32,367 | 154,684 |
| Net Cash Flow | $19,332 | $11,879 | $3,783 | $-122,317 | $-14,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | 45,631 | 67,074 | 39,419 | 27,472 | 17,264 |
| Capital Expenditure | -6,635 | -5,743 | -10,369 | -4,566 | -2,183 |
| Free Cash Flow | 38,996 | 61,331 | 29,050 | 22,906 | 15,081 |